One business that will be monitored in this upcoming week is the Edwards Lifesciences Corporation or EW. This corporation is traded on the New York Stock Exchange, and has been doing quite well compared to the rest of the pharmaceutical industry this past week. Figure 7.8 on the next page indicates a decline that happened in early February and the short rise in price afterwards. The SMA looks like it is about to cross the price line and there appears to be a breakout volume just before the rise in price. The one issue is that the MACD below the graph shows no momentum in favor of an uptrend. For this reason, stock was not bought will be monitored closely throughout week 2.